DataGait: Gait as a Measure of Functional Mobility on Discharge

DataGait：步态作为放电时功能活动性的衡量标准

• 批准号: 61571
• 金额: $ 9.43万
• 依托单位: 500MORE DIGITAL LTD
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=61571
• 关键词: DataGait; Gait; Measure; Functional; Mobility

This project is developing a user friendly App, which measures walking using your own phone, which can be used by clinicians and patients in the community, following discharge and/or recovering from COVID-19, to objectively measure their walking-quality, a key health indicator.We are learning about how COVID-19 affects people, but we now know that for some people it can be a long term illness with a slow recovery. People with ‘long covid’ experience a range of symptoms including fatigue, breathlessness during physical activity such as walking, tachycardia, pain and neuralgia. Patients with or recovering from COVID-19 adopt a walking style where they curb energy expenditure; this can be detected by gait analysis, by objectively measuring indirect cardio-respiratory functioning and fatigue. Walking is influenced by various complex interactions of the body's physical functioning, and can provide in-depth information on wellbeing and the general health status of an individual. NHS physiotherapists have identified the need for a system to monitor mobility alongside more specific individual assessments of breathlessness to guide their decision making in the treatment of these patients.Currently, specific walking tests are used clinically in a subjective way; we propose a remote monitoring system that will allow end-users to monitor their own health status, by capturing objective data for analysis, reporting, and feedback to clinicians. The system will use clinically validated and accepted measures of endurance and movement ability, via standardised tests including 10 metre and 2-minute walks. By instrumenting these tests with existing smartphone sensors, they will be objective providing both temporal (timing) and spatial (distance and walking speed) walking outcomes which have clinical value and use. In addition, our system will offer patients a means to capture a range of other measures to form an electronic ‘recovery diary’.This data will be shared with expert clinician therefore obtaining objective and longitudinal information which would support clinical decision making and risk assessments for people with suspected, confirmed or at risk of COVID-19. With the demand on frontline NHS staff ever increasing, and with most non-urgent out-patient appointments postponed, physiotherapists have specifically requested an application like this to be developed and deployed.We will work with key stakeholders, clinicians, end-users as well as world-renowned academics, to deliver a product which can be tested and deployed within six months from project start, and which can be adapted for other existing clinical conditions and recurring epidemics and pandemics to come. This gait technology was previously supported by InnovateUK ICURe26 (https://icure.uk/) to market validate, with contacts made with 100 health professionals and organisations and business leaders around the world.

该项目正在开发一款用户友好型应用程序，可以使用自己的手机测量步行情况，供临床医生和社区患者在出院和/或COVID-19康复后使用，以客观衡量他们的步行质量，这是一项关键的健康指标。我们正在了解COVID-19如何影响人类，但我们现在知道，对一些人来说，这可能是一种长期疾病，恢复缓慢。患有“长冠状病毒”的人会出现一系列症状，包括疲劳、行走等体力活动时呼吸困难、心动过速、疼痛和神经痛。COVID-19患者或正在康复的患者采取步行方式，控制能量消耗；这可以通过步态分析、客观测量间接心肺功能和疲劳来检测。步行受到身体机能各种复杂相互作用的影响，可以提供有关个人健康状况和一般健康状况的深入信息。NHS物理治疗师已经确定需要一个系统来监测活动能力，同时对呼吸困难进行更具体的个人评估，以指导他们在治疗这些患者时做出决策。目前，具体的步行测试在临床上以主观的方式使用；我们提出了一种远程监测系统，通过捕获客观数据进行分析、报告和反馈给临床医生，使最终用户能够监测自己的健康状况。该系统将通过包括10米和2分钟步行在内的标准化测试，使用临床验证和公认的耐力和运动能力测量方法。通过使用现有的智能手机传感器进行这些测试，它们将客观地提供时间（时间）和空间（距离和步行速度）的步行结果，具有临床价值和用途。此外，我们的系统将为患者提供一种方法来捕捉一系列其他措施，以形成电子“恢复日记”。这些数据将与专家临床医生共享，从而获得客观和纵向的信息，这些信息将支持疑似、确诊或有COVID-19风险的人的临床决策和风险评估。随着一线NHS工作人员的需求不断增加，以及大多数非紧急门诊预约推迟，物理治疗师特别要求开发和部署这样的应用程序。我们将与主要利益攸关方、临床医生、最终用户以及世界知名学者合作，提供一种产品，该产品可在项目开始后6个月内进行测试和部署，并可针对其他现有的临床条件和反复出现的流行病以及即将到来的流行病进行调整。这种步态技术先前由InnovateUK ICURe26 （https://icure.uk/）支持，以进行市场验证，并与世界各地的100名卫生专业人员和组织以及商业领袖建立了联系。